Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth K W To

Showing results (21-30 of 100) with videos related to

Pageof 10
Sort By:
Journal of Infection and Public Health|November 7, 2021
WITHDRAWN: Pretomanid for the treatment of Mycobacterium tuberculosis: Evidence on the development and clinical rolesGinenus Fekadu, Kenneth K W To, Joyce H S You
Frontiers in Oncology|June 11, 2021
Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New StrategiesKenneth K W To, Winnie Fong, William C S Cho
Experimental Cell Research|September 20, 2015
Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancerKenneth K W To, W W Leung, Simon S M Ng
Cell Cycle (Georgetown, Tex.)|June 23, 2005
Genetic instability: the dark side of the hypoxic responseKenneth K W To, Minori Koshiji, Stefanie Hammer, et al.
Journal of Cancer Research and Clinical Oncology|March 11, 2023
Repurposing of triamterene as a histone deacetylase inhibitor to overcome cisplatin resistance in lung cancer treatmentKenneth K W To, Ka M Cheung, William C S Cho
Frontiers in Pharmacology|May 20, 2024
Editorial: Tumour microenvironment in cancer research and drug discoveryNur Akmarina B M Said, Syed Mahmood, Kenneth K W To
Molecular Carcinogenesis|June 3, 2016
A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer developmentKenneth K W To, Wing W Leung, Simon S M Ng
Molecular and Cellular Biology|June 25, 2008
Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell lineKenneth K W To, Zhirong Zhan, Thomas Litman, et al.
Journal of Pharmacological Sciences|December 9, 2015
Synergistic cytotoxicity from combination of imatinib and platinum-based anticancer drugs specifically in Bcr-Abl positive leukemia cellsYuming Wei, Kenneth K W To, Steve C F Au-Yeung
European Journal of Pharmacology|January 30, 2018
PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagyKenneth K W To, William K K Wu, Herbert H F Loong
Pageof 10

Showing results (21-30 of 100) with videos related to

Sort By:
Pageof 10
Journal of Infection and Public Health|November 7, 2021
WITHDRAWN: Pretomanid for the treatment of Mycobacterium tuberculosis: Evidence on the development and clinical rolesGinenus Fekadu, Kenneth K W To, Joyce H S You
Frontiers in Oncology|June 11, 2021
Immunotherapy in Treating EGFR-Mutant Lung Cancer: Current Challenges and New StrategiesKenneth K W To, Winnie Fong, William C S Cho
Experimental Cell Research|September 20, 2015
Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancerKenneth K W To, W W Leung, Simon S M Ng
Cell Cycle (Georgetown, Tex.)|June 23, 2005
Genetic instability: the dark side of the hypoxic responseKenneth K W To, Minori Koshiji, Stefanie Hammer, et al.
Journal of Cancer Research and Clinical Oncology|March 11, 2023
Repurposing of triamterene as a histone deacetylase inhibitor to overcome cisplatin resistance in lung cancer treatmentKenneth K W To, Ka M Cheung, William C S Cho
Frontiers in Pharmacology|May 20, 2024
Editorial: Tumour microenvironment in cancer research and drug discoveryNur Akmarina B M Said, Syed Mahmood, Kenneth K W To
Molecular Carcinogenesis|June 3, 2016
A novel miR-203-DNMT3b-ABCG2 regulatory pathway predisposing colorectal cancer developmentKenneth K W To, Wing W Leung, Simon S M Ng
Molecular and Cellular Biology|June 25, 2008
Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell lineKenneth K W To, Zhirong Zhan, Thomas Litman, et al.
Journal of Pharmacological Sciences|December 9, 2015
Synergistic cytotoxicity from combination of imatinib and platinum-based anticancer drugs specifically in Bcr-Abl positive leukemia cellsYuming Wei, Kenneth K W To, Steve C F Au-Yeung
European Journal of Pharmacology|January 30, 2018
PPARgamma agonists sensitize PTEN-deficient resistant lung cancer cells to EGFR tyrosine kinase inhibitors by inducing autophagyKenneth K W To, William K K Wu, Herbert H F Loong
Pageof 10